76 related articles for article (PubMed ID: 1254412)
1. Components of vitreous-soluble proteins: effect of hyperoxia and age.
Chen CH; Patz A
Invest Ophthalmol; 1976 Mar; 15(3):228-32. PubMed ID: 1254412
[TBL] [Abstract][Full Text] [Related]
2. Localization of VEGF receptor-2 (KDR/Flk-1) and effects of blocking it in oxygen-induced retinopathy.
McLeod DS; Taomoto M; Cao J; Zhu Z; Witte L; Lutty GA
Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):474-82. PubMed ID: 11818393
[TBL] [Abstract][Full Text] [Related]
3. Effects of sustained hyperoxia on revascularization in experimental retinopathy of prematurity.
Gu X; Samuel S; El-Shabrawey M; Caldwell RB; Bartoli M; Marcus DM; Brooks SE
Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):496-502. PubMed ID: 11818396
[TBL] [Abstract][Full Text] [Related]
4. Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease. Studies in nondiabetic and diabetic subjects.
Meyer-Schwickerath R; Pfeiffer A; Blum WF; Freyberger H; Klein M; Lösche C; Röllmann R; Schatz H
J Clin Invest; 1993 Dec; 92(6):2620-5. PubMed ID: 7504689
[TBL] [Abstract][Full Text] [Related]
5. Fractalkine, a CX3C chemokine, as a mediator of ocular angiogenesis.
You JJ; Yang CH; Huang JS; Chen MS; Yang CM
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5290-8. PubMed ID: 17962485
[TBL] [Abstract][Full Text] [Related]
6. Localization of adenosine A2a receptor in retinal development and oxygen-induced retinopathy.
Taomoto M; McLeod DS; Merges C; Lutty GA
Invest Ophthalmol Vis Sci; 2000 Jan; 41(1):230-43. PubMed ID: 10634625
[TBL] [Abstract][Full Text] [Related]
7. Clinical and histopathologic features of canine oxygen-induced proliferative retinopathy.
McLeod DS; D'Anna SA; Lutty GA
Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1918-32. PubMed ID: 9727415
[TBL] [Abstract][Full Text] [Related]
8. [Expression of mRNA of vascular endothelial growth factor in a rat model of hyperoxia-induced retinopathy].
Zhang ZH; Jiang L; Qiao LX
Zhongguo Dang Dai Er Ke Za Zhi; 2007 Aug; 9(4):371-4. PubMed ID: 17706045
[TBL] [Abstract][Full Text] [Related]
9. Soluble forms of EphrinB2 and EphB4 reduce retinal neovascularization in a model of proliferative retinopathy.
Zamora DO; Davies MH; Planck SR; Rosenbaum JT; Powers MR
Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2175-82. PubMed ID: 15914639
[TBL] [Abstract][Full Text] [Related]
10. Prolonged tumor dormancy by prevention of neovascularization in the vitreous.
Brem S; Brem H; Folkman J; Finkelstein D; Patz A
Cancer Res; 1976 Aug; 36(8):2807-12. PubMed ID: 1277191
[TBL] [Abstract][Full Text] [Related]
11. [Expression and role of endostatin in the retina of oxygen-induced retinopathy mouse model].
Zhang MX; Zhang JJ; Yan M
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jul; 37(4):614-7. PubMed ID: 16909615
[TBL] [Abstract][Full Text] [Related]
12. Vascular adhesion molecules in vitreous from eyes with proliferative diabetic retinopathy.
Limb GA; Hickman-Casey J; Hollifield RD; Chignell AH
Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2453-7. PubMed ID: 10476819
[TBL] [Abstract][Full Text] [Related]
13. Effect of retinal laser photocoagulation on the activity of metalloproteinases and the alpha(2)-macroglobulin proteolytic state in the vitreous of eyes with proliferative diabetic retinopathy.
Sánchez MC; Luna JD; Barcelona PF; Gramajo AL; Juarez PC; Riera CM; Chiabrando GA
Exp Eye Res; 2007 Nov; 85(5):644-50. PubMed ID: 17826767
[TBL] [Abstract][Full Text] [Related]
14. Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor: implications for ocular angiogenesis.
Duh EJ; Yang HS; Haller JA; De Juan E; Humayun MS; Gehlbach P; Melia M; Pieramici D; Harlan JB; Campochiaro PA; Zack DJ
Am J Ophthalmol; 2004 Apr; 137(4):668-74. PubMed ID: 15059706
[TBL] [Abstract][Full Text] [Related]
15. Role of the vascular endothelial growth factor isoforms in retinal angiogenesis and DiGeorge syndrome.
Stalmans I
Verh K Acad Geneeskd Belg; 2005; 67(4):229-76. PubMed ID: 16334858
[TBL] [Abstract][Full Text] [Related]
16. Quantitative MR imaging study of intravitreal sustained release of VEGF in rabbits.
Alikacem N; Yoshizawa T; Nelson KD; Wilson CA
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1561-9. PubMed ID: 10798677
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of vitreous proteins in proliferative diabetic retinopathy.
Kim SJ; Kim S; Park J; Lee HK; Park KS; Yu HG; Kim Y
Curr Eye Res; 2006 Mar; 31(3):231-40. PubMed ID: 16531280
[TBL] [Abstract][Full Text] [Related]
18. Transient exposure of rat pups to hyperoxia at normobaric and hyperbaric pressures does not cause retinopathy of prematurity.
Calvert JW; Zhou C; Zhang JH
Exp Neurol; 2004 Sep; 189(1):150-61. PubMed ID: 15296845
[TBL] [Abstract][Full Text] [Related]
19. The rationale of photocoagulation therapy for proliferative diabetic retinopathy: a review and a model.
Wolbarsht ML; Landers MB
Ophthalmic Surg; 1980 Apr; 11(4):235-45. PubMed ID: 6155650
[TBL] [Abstract][Full Text] [Related]
20. [The current data on the proliferative process in diabetic retinopathy].
Mazurina NK
Vestn Oftalmol; 1999; 115(3):37-40. PubMed ID: 10432854
[No Abstract] [Full Text] [Related]
[Next] [New Search]
